| Financial Year |
March 31 2023 |
| Monetary Funds |
476,347,063.52 |
| Held-for-trading Financial Assets |
97,285,066.20 |
| Notes Receivable |
217,962,914.41 |
| Accounts Receivable |
928,102,947.07 |
| Advances to Suppliers |
257,559,243.67 |
| Other Receivables |
107,647,994.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
755,050.70 |
| Inventories |
566,453,947.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,207,274.56 |
| Total Current Assets |
2,789,008,569.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
56,109,139.38 |
| Investment Properties |
92,149,603.06 |
| Fixed Assetes |
1,217,693,244.94 |
| Under-construction Projects |
327,547,303.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
373,203,582.76 |
| R&D expenses |
-- |
| Goodwill |
16,455,894.92 |
| Long-Term Deferred and Prepaid Expenses |
37,343,889.98 |
| Deferred Income Tax Assets |
71,582,065.70 |
| Other Non-Current Assets |
76,473,909.30 |
| Sub-Total of Non-Current Assets |
2,428,455,347.15 |
| Total Assets |
5,217,463,916.27 |
| Short-Term Loans |
239,929,817.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
137,385,479.05 |
| Accounts Payable |
421,311,253.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,640,817.14 |
| Taxes Payable |
48,726,708.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
136,266,600.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
458,287,040.93 |
| Other Current Liabilities |
3,931,454.71 |
| Sub-Total of Current Liabilities |
1,634,676,926.43 |
| Long-term Loans |
100,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
484,836.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
36,300,000.00 |
| Deferred Income Tax Liabilities |
34,459,489.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
311,264,848.94 |
| Total Liabilities |
1,945,941,775.37 |
| Paid-In Capital(Or Share Stock) |
529,129,329.00 |
| Capital Surplus |
1,603,308,359.89 |
| Surplus Reserve |
74,726,055.77 |
| LESS:Treasury Stock |
40,818,188.04 |
| Undistributed Profits |
943,470,365.51 |
| Minority Stockholder's Interest |
99,682,272.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,171,839,868.01 |
| Owner's Equity（Stockholder's Equity） |
3,271,522,140.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,217,463,916.27 |
